CARDIOMAB Trademark

Trademark Overview

On Tuesday, November 14, 2017, a trademark application was filed for CARDIOMAB with the United States Patent and Trademark Office. The USPTO has given the CARDIOMAB trademark a serial number of 87684501. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 22, 2021. This trademark is owned by CardioVax, LLC. The CARDIOMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
cardiomab

General Information

Serial Number87684501
Word MarkCARDIOMAB
Filing DateTuesday, November 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements

Goods and ServicesPharmaceutical research and development
Pseudo MarkCARDIO MAB

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 27, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameABCENTRA
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLOS ANGELES, CA 90067
Party NameCardioVax, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLos Angeles, CA 90067
Party NameCardioVax, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLos Angeles, CA 90067

Trademark Events

Event DateEvent Description
Monday, February 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 26, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, August 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 7, 2020EXTENSION 4 GRANTED
Saturday, July 11, 2020EXTENSION 4 FILED
Thursday, August 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, July 11, 2020TEAS EXTENSION RECEIVED
Thursday, December 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 10, 2019EXTENSION 3 GRANTED
Tuesday, December 10, 2019EXTENSION 3 FILED
Tuesday, December 10, 2019TEAS EXTENSION RECEIVED
Tuesday, July 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 12, 2019EXTENSION 2 GRANTED
Friday, July 12, 2019EXTENSION 2 FILED
Friday, July 12, 2019TEAS EXTENSION RECEIVED
Wednesday, January 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 14, 2019EXTENSION 1 GRANTED
Monday, January 14, 2019EXTENSION 1 FILED
Monday, January 14, 2019TEAS EXTENSION RECEIVED
Tuesday, July 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 3, 2018NON-FINAL ACTION E-MAILED
Saturday, March 3, 2018NON-FINAL ACTION WRITTEN
Friday, February 23, 2018ASSIGNED TO EXAMINER
Monday, November 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cardiomab development research pharmaceutical